Phase 2 Lung Cancer Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• People who are in good overall health and able to carry out daily activities with little to no limitation, based on a standard medical scoring system called the ECOG scale (scores 0 or 1).
• People who have been diagnosed with a specific type of lung cancer called non-small cell lung cancer (NSCLC) at Stage II or IIIA, which has not yet been treated and has been confirmed by a tissue sample, and where surgery to remove the cancer is considered possible.
• People who have at least one area of cancer that can be clearly measured on scans, according to a standard measurement system called RECIST 1.1.
• People whose major organs (such as kidneys, liver, and bone marrow) are functioning well enough to meet the trial's requirements.

Who may not be able to join:

• People whose lung cancer is a mixture of non-small cell lung cancer and another type called small cell lung cancer.
• People who have had another active cancer diagnosis within the past 3 years before joining the trial.
• People who have a known active autoimmune disease (a condition where the immune system mistakenly attacks the body).
• People who have taken medications that suppress the immune system within the 14 days before the first dose of the trial treatment.
• People who have other serious medical conditions that are not well controlled (confirm with trial site for specifics).

Important: Always verify eligibility with the trial site directly before applying.